Nuvectis Pharma, Inc. (NVCT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

21.81M
Year ended 2025-12-31
+19.9%
3-year compound annual growth
2021-12-31: 4.27M2022-12-31: 12.66M2023-12-31: 15.56M2024-12-31: 17.11M2025-12-31: 21.81M21.81M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3121.81M+27.5%2026-02-11, From 2025-01-01
2024-12-3117.11M+10.0%2026-02-11, From 2024-01-01
2023-12-3115.56M+22.9%2025-02-25, From 2023-01-01
2022-12-3112.66Mn/c2024-03-05, From 2022-01-01
2021-12-314.27Mn/a2023-03-08, From 2021-01-01